about
Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine effortsFunctional impact of colorectal cancer-associated mutations in the transcription factor E2F4.Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes.E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments.
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Benjamin Bian
@ast
Benjamin Bian
@en
Benjamin Bian
@es
Benjamin Bian
@nl
type
label
Benjamin Bian
@ast
Benjamin Bian
@en
Benjamin Bian
@es
Benjamin Bian
@nl
prefLabel
Benjamin Bian
@ast
Benjamin Bian
@en
Benjamin Bian
@es
Benjamin Bian
@nl
P106
P31
P496
0000-0001-8691-5292